Calcitonin gene-related peptide (CGRP) inhibits apoptosis in human osteoblasts by ß-catenin stabilization

Journal of Cellular Physiology

Volumn 225, Issue 3, 2010, Pages 701-708

  Mrak, Emanuela ^a,b   Guidobono, Francesca ^b   Moro, Gianluigi ^a   Fraschini, Gianfranco ^a   Rubinacci, Alessandro ^a   Villa, Isabella ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; BETA CATENIN; CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE[8-37]; CYCLIC AMP DEPENDENT PROTEIN KINASE; DEXAMETHASONE; GLYCOGEN SYNTHASE KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PROTEASOME; WNT PROTEIN; CALCITONIN GENE RELATED PEPTIDE (8 37); CALCITONIN GENE-RELATED PEPTIDE (8-37); CTNNB1 PROTEIN, HUMAN; ENZYME ACTIVATOR; FORSKOLIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; ISOQUINOLINE DERIVATIVE; PEPTIDE FRAGMENT; PROTEIN KINASE INHIBITOR; SULFONAMIDE;

ADULT; AGED; APOPTOSIS; ARTICLE; BIOACCUMULATION; BONE CELL; BONE DENSITY; BONE METABOLISM; BONE REGENERATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NERVE FIBER; OSSIFICATION; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; ACTIVE TRANSPORT; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; TIME;

MUS MUSCULUS;

ACTIVE TRANSPORT, CELL NUCLEUS; AGED; APOPTOSIS; BETA CATENIN; BONE REGENERATION; CALCITONIN GENE-RELATED PEPTIDE; CELL SURVIVAL; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DEXAMETHASONE; ENZYME ACTIVATORS; FORSKOLIN; GLYCOGEN SYNTHASE KINASE 3; HUMANS; ISOQUINOLINES; MIDDLE AGED; OSTEOBLASTS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN STABILITY; RNA, MESSENGER; SIGNAL TRANSDUCTION; SULFONAMIDES; TIME FACTORS; WNT PROTEINS;

EID: 77957838269     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22266     Document Type: Article

References (38)

1. Akopian A, Demulder A, Ouriaghli F, Corazza F, Fondu P, Bergmann P. 2000. Effects of CGRP on human osteoclast-like cells formation: A possible connection with the bone loss in neurological disorders? Peptides 21: 559-564.
2. Almeida M, Han L, Bellido T, Manolagas SC, Kousteni S. 2005. Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. J Biol Chem 280: 41342-41351.
3. Amara SG, Jones V, Rosenfeld MG, Ong ES, Evans RM. 1982. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptides products. Nature 29: 240-249.
4. Babij P, Zhao W, Small C, Kharode Y, Yaworsky PJ, Bouxsein ML, Reddy PS, Bodine PV, Robinson JA, Bhat B, Marzolf J, Moran RA, Bex F. 2003. High bone mass in mice expressing a mutant LRP5 gene. J Bone Miner Res 18: 960-974.
5. Ballica R, Valentijn K, Khachatryan A, Guerder S, Kapadia S, Gundberg C, Gilligan T, Flavell RA, Vignery A. 1999. Targeted expression of calcitonin gene-related peptide to osteoblasts increase bone density in mice. J Bone Miner Res 14: 1067-1074.
6. Baron R, Rawadi G. 2007. Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton. Endocrinology 148: 2635-2643.
7. Bodine PV. 2008. Wnt signaling control of bone cell apoptosis. Cell Res 18: 248-253.
8. Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP. 2002. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346: 1513-1521.
9. Burns DM, Stehno-Bittel L, Kawase T. 2004. Calcitonin gene-related peptide elevates calcium and polarizes membrane potential in MG-63 cells by both cAMP-independent and -dependent mechanisms. Am J Physiol Cell Physiol 287: C457-C467.
10. Drissi H, Hott M, Marie PJ, Lasmoles F. 1997. Expression of the CT/CGRP gene and its regulation by dibutyryl cyclic adenosine monophosphate in human osteoblastic cells. J Bone Miner Res 12: 1805-1814.
11. 2+ concentrations but not cyclic AMP formation in CGRP receptor-positive osteosarcoma cells (OHS-4). Cytokine 11: 200-207.
12. Fang X, Yu SX, Lu Y, Bast RC, Jr., Woodgett JR, Mills GB. 2000. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A. Proc Natl Acad Sci USA 97: 11960-11965.
13. Gehron-Robey P, Termine JD.- 1985. Human bone cells in vitro. Calcif Tissue Int 37: 453-460.
14. Hilairet S, Belanger C, Bertrand J, Laperrière A, Foord SM, Bouvier M. 2001. Agonist-promoted internalization of a ternary complex between calcitonin receptor-like receptor, receptor activity-modifying protein 1 (RAMP1) and ß-arrestin. J Biol Chem 276: 42182-42190.
15. Hukkanen M, Konttinen YT, Santavirta S, Paavolainen P, Gu XH, Terenghi G, Polak JM. 1993. Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during of rat healing fracture suggests neural involvement in bone growth and remodeling. Neuroscience 54: 969-979.
16. Imai S, Rauvala H, Konttinen YT, Tokunaga T, Maeda T, Hukuda S, Santavirta S. 1997. Efferent targets of osseues CGRP-immunoreactive nerve fiber before and after bone destruction in adjuvant arthritic rat: An ultramorphological study on their terminal-target relations. J Bone Miner 12: 1018-1027.
17. Irie K, Hara-Irie F, Ozawa H, Yajima T. 2002. Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling. Microsc Res Tech 58: 85-90.
18. Kakar S, Einhorn TA, Vora S, Miara LJ, Hon G, Wigner NA, Toben D, Jacobsen KA, Al-Sebaei MO, Song M, Trackman PC, Morgan EF, Gerstenfeld LC, Barnes GL. 2007. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 22: 1903-1912.
19. Kato M, Patel MS, Levasseur R, Lobov I, Chang BH, Glass DA II, Hartmann C, Li L, Hwang TH, Brayton CF, Lang RA, Karsenty G, Chan L. 2002. Cbfa1 independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in LRP5, a Wnt coreceptor. J Cell Biol 157: 303-314.
20. Krishnan V, Bryant HU, Macdougald OA. 2006. Regulation of bone mass by Wnt signaling. J Clin Invest 116: 1202-1209.
21. Li J, Kreicbergs A, Bergstrom J, Stark A, Ahmed M. 2007. Site-specific CGRP innervation coincides with bone formation during fracture healing and modeling: A study in rat angulated tibia. J Orthop Res 25: 1204-1212.
22. Morvan F, Boulukos K, Clément-Lacroix P, Roman-Roman S, Suc-Royer I, Vayssière B, Ammann P, Martin P, Pinho S, Pognonec P, Mollat P, Niehrs C, Baron R, Rawadi G. 2006. Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass. J Bone Miner Res 21: 934-945.
23. Naot D, Cornish J. 2008. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism. Bone 43: 813-818.
24. Novak A, Dedhar S. 1999. Signaling through Beta-catenin and Lef/Tcf. Cell Mol Life Sci 56: 523-537.
25. Onuoha GN, Alpar EK. 2000. Elevation of plasma CGRP and SP levels in orthopedic patients with fracture neck of femur. Neuropeptides 34: 116-120.
26. Rawadi G, Roman-Roman S. 2005. Wnt signaling pathway: A new target for the treatment of osteoporosis. Expert Opin Ther Targets 9: 1063-1077.
27. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. 1996. Binding of GSK3ß to the APC-ß-catenin complex and regulation of complex assembly. Science 272: 1023-1026.
28. Schinke T, Liese S, Priemel M, Haberland M, Schilling AF, Catala-Lehnen P, Blicharski D, Rueger JM, Gagel RF, Emeson RB, Amling M. 2004. Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide. J Bone Miner Res 19: 2049-2056.
29. Silkstone D, Hong H, Alman BA. 2008. Beta-catenin in the race to fracture repair: In it to Wnt. Nat Clin Pract Rheumatol 4: 413-419.
30. Suzuki A, Ozono K, Kubota T, Kondou H, Tachikawa K, Michigami T. 2008. PTH/cAMP/PKA signaling facilitates canonical Wnt signaling via inactivation of glycogen synthase kinase-3ß in osteoblastic Saos-2 cells. J Cell Biochem 104: 304-317.
31. Taurin S, Sandbo N, Yau DM, Sethakorn N, Dulin NO. 2008. Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells. Am J Physiol Cell Physiol 294: C1169-C1174.
32. Tobimatsu T, Kaji H, Sowa H, Naito J, Canaff L, Hendy GN, Sugimoto T, Chihara K. 2006 Parathyroid hormone increases Β-catenin levels through Smad3 in mouse osteoblastic cells. Endocrinology 147: 2583-2590.
33. Uzan B, Villemin A, Garel JM, Cressent M. 2008. Adrenomedullin is anti-apoptotic in osteoblasts through CGRP1 receptors and MEK-ERK pathway. J Cell Physiol 215: 122-128.
34. Villa I, Melzi R, Pagani F, Ravasi F, Rubinacci A, Guidobono F. 2000. Effects of calcitonin gene-related peptide and amylin on human osteoblast-like cells proliferation. Eur J Pharmacol 409: 273-278.
35. Villa I, Dal Fiume C, Maestroni A, Rubinacci A, Ravasi F, Guidobono F. 2003. Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity. Am J Physiol Endocrinol Metab 284: E627-E633.
36. Villa I, Mrak E, Rubinacci A, Ravasi F, Guidobono F. 2006. CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. Am J Physiol Cell Physiol 291: C529-C537.
37. Wang L, Shi X, Zhao R, Halloran BP, Clark DJ, Jacobs CR, Kingery WS. 2010. Calcitonin-gene-related peptide stimulates stromal cell osteogenic differentiation and inhibits RANKL induced NF-ΚB activation, osteoclastogenesis and bone resorption. Bone 46: 1369-1379.
38. Zhang WZ, Yu SF, Zheng LF. 1994. Effects of calcitonin gene-related peptide on bone resorption mediated by interleukin-1. Chin Med J (Engl) 107: 351-354.